해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 12.27. (금)

구분	보고서(영문)
제약/바이오/ 임상시험 (11건)	Cell and Gene Therapy Companies Must Demonstrate Strong Value Proposition for Investment
	RSV Prophylactic Market to Reach $6.2 Billion in 8MM by 2030
	Schizophrenia Market Expected to Reach $17.0 Billion Across the 7MM by 2031
	DREAM-HF Trial Sheds Positive Light on Revascor for Ischemic HF
	Positive Interim Phase IIb Data Shows Promise of First Blood-Stage Malaria Vaccine
	Biotech Bounces Back as Venture Funding Grows $3.8 Million from 2023 to 2024YTD
	Christmas has come early for AbbVie as Tavapadon achieves positive topline results in Phase III TEMPO-2 Trial
	Setback for UK Pharma as Government Sets Unexpectedly High VPAG Payback Rate in 2025
	Emerging Market Quarterly Mergers, Acquisitions, and Financing – Q4 2024
	Bio/Pharmaceutical Outsourcing Report, December 2024
	From Davids to Goliaths: The GLP-1R Gold Rush
질환별 (7건)	Unmet Needs in the Chronic Hand Eczema Treatment Landscape
	New Study Highlights the Increasing Incidence of Late-Onset Multiple Sclerosis in Italy
	Bowel Cancer Cases are Rising Sharply in Younger Adult Population
	Wrapping up the Year: Top HIV Drug Mechanisms “Sleighing” Through Late-Stage Pipeline
	New Screening Recommendations for Critical Congenital Heart Defects
	One-Third of Psoriatic Arthritis Cases Go Undiagnosed in Key Pharmaceutical Markets
	Sodium Intake Linked to Atopic Dermatitis and Disease Severity
기타 (3건)	Waist-to-Hip Ratio a Better Predictor of Colorectal Cancer Risk than BMI
	Knock-on Effects of Alcohol Consumption During the COVID-19 Pandemic in Brazil
	Reprieve for WuXi as Biosecure Vote Likely Pushed to 2025